Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Sofosbuvir As a Potential Option for the Treatment of Covid-19 Publisher Pubmed



Nourian A1 ; Khalili H1
Authors

Source: Acta Biomedica Published:2020


Abstract

Summary. Sofosbuvir may be a potential option in the treatment of COVID-19 based on the similarity between the replication mechanisms of the HCV and the coronavirus. According the limited experimental evidences, it is hypothesized that sofosbuvir might be a potential option to improve care of patients with COVID-19 especially at the start of the disease and before invasion of the virus into the lung parenchymal cells. Efficacy and safety of sofosbuvir in treatment of COVID-19 may be considered in future clinical studies. (www.actabiomedica.it). © Mattioli 1885.
Related Docs
View other Related Docs
1. Efficacy and Safety of Sofosbuvir/ Ledipasvir in Treatment of Patients With Covid-19; a Randomized Clinical Trial, Acta Biomedica (2020)
2. Evaluation of the Efficacy of Sofosbuvir Plus Daclatasvir in Combination With Ribavirin for Hospitalized Covid-19 Patients With Moderate Disease Compared With Standard Care: A Single-Centre, Randomized Controlled Trial, Journal of Antimicrobial Chemotherapy (2020)
3. Sofosbuvir and Daclatasvir Compared With Standard of Care in the Treatment of Patients Admitted to Hospital With Moderate or Severe Coronavirus Infection (Covid-19): A Randomized Controlled Trial, Journal of Antimicrobial Chemotherapy (2020)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (3)
Anahita Sadeghi (3)
Other Related Docs
4. A Mini-Review on Sofosbuvir and Daclatasvir Treatment in Coronavirus Disease 2019, New Microbes and New Infections (2021)
5. Antiviral Therapy Inmanagement of Covid-19: A Systematic Review on Current Evidence, Archives of Academic Emergency Medicine (2020)
6. Sotrovimab in Solid Organ Transplant Recipients With Covid-19: A Systematic Review and Meta-Analysis, Korean Journal of Transplantation (2023)
7. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
8. Sofosbuvir/Daclatasvir Regimens for the Treatment of Covid-19: An Individual Patient Data Meta-Analysis, Journal of Antimicrobial Chemotherapy (2021)
9. Covid-19: Transmission, Prevention, and Potential Therapeutic Opportunities, Clinica Chimica Acta (2020)
10. Case Fatality Rate of Covid-19: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2021)
11. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
12. The Impact of Sofosbuvir/Daclatasvir or Ribavirin in Patients With Severe Covid-19, Journal of Antimicrobial Chemotherapy (2020)
13. Monoclonal Antibody As a Potential Anti-Covid-19, Biomedicine and Pharmacotherapy (2020)
14. Antiretrovirals for Prophylaxis Against Covid-19: A Comprehensive Literature Review, Journal of Clinical Pharmacology (2021)
15. Covid-19 Immunotherapy: Treatment Based on the Immune Cell-Mediated Approaches, International Immunopharmacology (2022)
16. How the First Cases of Covid-19 in 10 Countries Become Infected? a Case Series, Respiratory Medicine Case Reports (2023)
17. Pathological Effects of Sars-Cov-2 on Hematological and Immunological Cells: Alterations in Count, Morphology, and Function, Pathology Research and Practice (2022)
18. Late Complications of Covid-19; a Systematic Review of Current Evidence, Archives of Academic Emergency Medicine (2020)
19. Comparison of Effectiveness and Safety of Molnupiravir Versus Sotrovimab for Covid-19: A Systematic Review and Meta-Analysis, Immunity# Inflammation and Disease (2024)
20. Covid-19 Outcomes in Kidney Transplant Recipients Receiving a Combination of Sofosbuvir-Daclatasvir Treatment; a Single-Center Study, Journal of Renal Injury Prevention (2023)